Showing results (21-30 of 162) with videos related to
Sort By:
Pageof 17
Molecular Neurobiology|March 10, 2015
Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner?Kenneth Blum, Marcelo Febo, Panayotis K Thanos, et al.Psychology Research and Behavior Management|October 27, 2023
"TO BE OR NOT TO BE" GWAS Ends the Controversy about the DRD2 Gene as a Determinant of Reward Deficiency Syndrome (RDS)Kenneth Blum, Panayotis K Thanos, Colin Hanna, et al.BMC Psychiatry|January 9, 2008
Evaluating dose response from flexible dose clinical trialsIlya Lipkovich, David H Adams, Craig Mallinckrodt, et al.Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|June 4, 2015
Psychopharmacologic Management in Integrated Care: Challenges for Residency EducationNicolas Badre, David Baron, Lawrence Gross, et al.International Journal of Environmental Research and Public Health|August 6, 2020
Developing a Japanese Version of the Baron Depression Screener for Athletes among Male Professional Rugby PlayersYasutaka Ojio, Asami Matsunaga, Kensuke Hatakeyama, et al.Journal of Systems and Integrative Neuroscience|September 16, 2020
Improving naltrexone compliance and outcomes with putative pro- dopamine regulator KB220, compared to treatment as usualKenneth Blum, Lisa Lott, David Baron, et al.Toxicology and Applied Pharmacology|January 25, 2011
Suppressive effects of acid-forming diet against the tumorigenic potential of pioglitazone hydrochloride in the urinary bladder of male ratsKeiichiro Sato, Yasuyuki Awasaki, Hitoshi Kandori, et al.European Journal of Anaesthesiology|April 24, 2015
Real-time in-vivo imaging of pulmonary capillary perfusion using probe-based confocal laser scanning endomicroscopy in pigs: An interventional laboratory studySybille Gruber, Isabella Spielauer, Stefan Böhme, et al.Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|February 26, 2009
Effects of open-label atomoxetine on African-American and Caucasian pediatric outpatients with attention-deficit/hyperactivity disorderTodd M Durell, Andres J Pumariega, Eugenio M Rothe, et al.Frontiers in Bioscience (Landmark Edition)|April 15, 2017
Substance use disorder a bio-directional subset of reward deficiency syndromeKenneth Blum, Mark Gold, Zsolt Demetrovics, et al.Pageof 17